Redirecting T lymphocyte specificity by T cell receptor gene transfer – A new era for immunotherapy
- 28 February 2007
- journal article
- review article
- Published by Elsevier in Molecular Aspects of Medicine
- Vol. 28 (1), 115-142
- https://doi.org/10.1016/j.mam.2006.12.006
Abstract
No abstract availableKeywords
This publication has 93 references indexed in Scilit:
- Cancer Regression in Patients After Transfer of Genetically Engineered LymphocytesScience, 2006
- Reconstitution of paired T cell receptor α- and β-chains from microdissected single cells of human inflammatory tissuesProceedings of the National Academy of Sciences, 2006
- Transduction of an HLA-DP4–restricted NY-ESO-1–specific TCR into Primary Human CD4+ LymphocytesJournal of Immunotherapy, 2006
- Therapeutic gene causing lymphomaNature, 2006
- Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapyThe Journal of Experimental Medicine, 2006
- Redirecting human CD4+ T lymphocytes to the MHC class I-restricted melanoma antigen MAGE-A1 by TCR αβ gene transfer requires CD8αGene Therapy, 2004
- Dual T cell receptor T cells with two defined specificities mediate tumor suppression via both receptorsEuropean Journal of Immunology, 2004
- Retroviral Transduction of a T Cell Receptor Specific for an Epstein–Barr Virus-Encoded PeptideClinical Immunology, 2001
- Nonmyeloablative Immunosuppressive Regimen Prolongs In Vivo Persistence of Gene-Modified Autologous T Cells in a Nonhuman Primate ModelJournal of Virology, 2001
- RNA Levels of Human Retrovirus Receptors Pit1 and Pit2 Do Not Correlate with Infectibility by Three Retroviral Vector PseudotypesHuman Gene Therapy, 1998